Daily Archives: February 15, 2022

Acupuncture, Medicare.gov; Bath C, How Interested Are Patients in Integrative Therapies, and How Much Are They Willing to Pay for Them, The ASCO Post, April 25, 2021; Biofeedback Therapy, CMS.gov; Calcagni N, et al., A systematic review of complementary and alternative medicine in oncology, PloS one, October 17, 2019; Cancer Patient Experience Survey Resources, December 10, 2019; Cancer Support Services Volumes, Staffing, and Operations Benchmark Generator, July 21, 2017; Cavallo J, "Integrative Medicine Showing Benefits in Cancer Management," The ASCO Post, November 15, 2012; Chiropractic services, Medicare.gov; "CMS' chemotherapy measure: What cancer programs need to know," December 3, 2019; Complementary, Alternative, or Integrative Health: What's In a Name? NCCIH.nih.gov, April 2021; "Complementary and Alternative Medicine," Cancer.gov; Garcia M, et al., Systematic review of acupuncture in cancer care: a synthesis of the evidence, Journal of Clinical Oncology, March 1, 2013; Horneber M, et al., How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis," Integrative Cancer Therapies, October 2011; "How to Keep Your Cancer Patients Out of the ED," January 2, 2018; "Integrative Medicine," Cancer.net; Integrative medicine cancer care, Aurora Health Care; Mao J, et al., Complementary and alternative medicine use among cancer survivors, Journal of Cancer Survivorship, October 6, 2010; Nahin RL, et al., Insurance Coverage for Complementary Health Approaches Among Adult Users: United States, 2002 and 2012, National Center for Health Statistics, January 2016; Nutrition therapy services, Medicare.gov; Oberoi S, et al., Association of Mindfulness-Based Interventions With Anxiety Severity in Adults With Cancer, JAMA Network Open, August 7, 2020; Sabin G, The Role of Philanthropy In The Evolution Of Integrative Medicine, Fonconsulting; Sun C, "Lesser known health perks your plan may offer," Aetna; Support services insights: Are you providing the right complementary medicine services? August 29, 2016; The support services cancer programs are providingand how theyre funding them, July 12, 2018; Wayne P, et al., Tai Chi and Qigong for cancer-related symptoms and quality of life: a systematic review and meta-analysis, Journal of Cancer Survivorship, April 12, 2018; "Will My Insurance Cover Complementary and Integrative Therapies?" American Cancer Society, August 25, 2021.

Here is the original post:

Integrative Medicine in Oncology - The Daily Briefing

Prince Charles, proud to be the Enemy of the Enlightenment.

Edzard Ernst has a new book out: Charles, The Alternative Prince: An Unauthorized Biography. I wrote a full book review that will appear in the next issue of Skeptical Inquirer magazine, but I wanted to give my readers on Science-Based Medicine a heads-up. Charles efforts to promote alternative medicine have been mentioned many times on SBM, but readers may not appreciate the depth of his folly. I know I didnt, until I read this book. The full story has never been told until now.

Ernst uses Prince Charles own words to demonstrate his ignorance of science and medicine. He thinks conventional medicine is nothing but pills and procedures. At the age of 34, he had the chutzpah to lecture to the members of the British Medical Association on the power of spiritualism, urging them to follow their intuition rather than look for scientific evidence. He has always been intuitively averse to scientific materialism and was drawn to mysticism. He fell under the influence of disreputable advisers such as Laurens van der Post, who was a compulsive liar and who impregnated a 14-year-old girl.

In addition to haranguing doctors, he has been lobbying politicians to get the NHS to pay for alternative medicine. Fortunately, his efforts have had little effect.

He says the evidence of experience is just as important as scientific evidence. He repeatedly falls for the post hoc ergo propter hoc fallacy and other logical fallacies. Ernst wonders if he is really that ignorant about science and logic, or if is this motivated ignorance, ignoring anything that disagrees with his opinions.

Prince Charles is convinced that acupuncture and Gerson therapy are fully supported by scientific evidence, and he endorses diagnostic methods like foot reflexology, iridology, and pulse diagnosis, methods that have been tested and shown not to work. He is a firm believer in homeopathy.

Perhaps the worst thing is that he is proud of being called the enemy of the Enlightenment. He is clearly anti-science. He calls for more research into alternative medicine, but he doesnt mean what we mean by research. He doesnt want research to ask if a treatment is effective, he wants it to demonstrate that it is effective, and that it would save money (which it would not).

Ernsts book offers many more fascinating details. I hope some of you will read it. You may be as shocked as I was.

Harriet Hall, MD also known as The SkepDoc, is a retired family physician who writes about pseudoscience and questionable medical practices. She received her BA and MD from the University of Washington, did her internship in the Air Force (the second female ever to do so), and was the first female graduate of the Air Force family practice residency at Eglin Air Force Base. During a long career as an Air Force physician, she held various positions from flight surgeon to DBMS (Director of Base Medical Services) and did everything from delivering babies to taking the controls of a B-52. She retired with the rank of Colonel. In 2008 she published her memoirs, Women Aren't Supposed to Fly.

View all posts

Follow this link:

Prince Charles and Alternative Medicine - Science Based Medicine

Alternative and Complementary Medicine Market 2022

Alternative and Complementary Medicine Marketreport delivers a complete overview of key components like drivers, limitations, historic and current trends, technical development, and future growth. Research report contains company analysis, size, share, revenue and sales of the company, current advancements. Alternative and Complementary Medicine market analysis also focuses on the global key top industry players in the market, with details such as company profiles, capacity, production, price, cost, revenue.

The global Alternative and Complementary Medicine market size is projected to reach USD 12180 million by 2028, from USD 5752.2 million in 2021, at a CAGR of 10.8% during 2022-2028.

Get a Sample Copy of the Report at https://www.reportsandmarkets.com/sample-request/global-alternative-and-complementary-medicine-market-4270682?utm_source=thetalkingdemocrat&utm_medium=47

The top players are concentrating mostly on technical developments in order to increase efficiency. The long-term growth patterns for this market can be taken by continuing the current development progresses and financial strength to participate in the best strategies.

By Company @ Iyengar Yoga Institute, Nordic Naturals, Herbal Hills, John Schumachers Unity Woods Yoga Center, Pure encapsulations, Yoga Tree, Columbia Nutritional Inc., Helio USA Inc., Deepure Plus, Quantum Touch Inc, The Healing Company, and Herb Pharm

By Region

TOC of Global Alternative and Complementary Medicine Market Insights and Forecast to 2028

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Alternative and Complementary Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.3 Market by Application

1.3.1 Global Alternative and Complementary Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Alternative and Complementary Medicine Market Perspective (2017-2028)

2.2 Alternative and Complementary Medicine Growth Trends by Region

2.2.1 Alternative and Complementary Medicine Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Alternative and Complementary Medicine Historic Market Size by Region (2017-2022)

2.2.3 Alternative and Complementary Medicine Forecasted Market Size by Region (2023-2028)

2.3 Alternative and Complementary Medicine Market Dynamics

2.3.1 Alternative and Complementary Medicine Industry Trends

2.3.2 Alternative and Complementary Medicine Market Drivers

2.3.3 Alternative and Complementary Medicine Market Challenges

2.3.4 Alternative and Complementary Medicine Market Restraints

Inquire or Share Your Questions If Any Before the Purchasing This Report:https://www.reportsandmarkets.com/enquiry/global-alternative-and-complementary-medicine-market-4270682?utm_source=thetalkingdemocrat&utm_medium=47

3 Competition Landscape by Key Players

3.1 Global Top Alternative and Complementary Medicine Players by Revenue

3.1.1 Global Top Alternative and Complementary Medicine Players by Revenue (2017-2022)

3.1.2 Global Alternative and Complementary Medicine Revenue Market Share by Players (2017-2022)

3.2 Global Alternative and Complementary Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Alternative and Complementary Medicine Revenue

3.4 Global Alternative and Complementary Medicine Market Concentration Ratio

3.4.1 Global Alternative and Complementary Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alternative and Complementary Medicine Revenue in 2021

3.5 Alternative and Complementary Medicine Key Players Head office and Area Served

3.6 Key Players Alternative and Complementary Medicine Product Solution and Service

3.7 Date of Enter into Alternative and Complementary Medicine Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Alternative and Complementary Medicine Breakdown Data by Type

4.1 Global Alternative and Complementary Medicine Historic Market Size by Type (2017-2022)

4.2 Global Alternative and Complementary Medicine Forecasted Market Size by Type (2023-2028)

5 Alternative and Complementary Medicine Breakdown Data by Application

5.1 Global Alternative and Complementary Medicine Historic Market Size by Application (2017-2022)

5.2 Global Alternative and Complementary Medicine Forecasted Market Size by Application (2023-2028)

Table of contents:

Alternative and Complementary Medicine Global Market Research Report 2021 (Updated)

1 Market Overview

2 Manufacturers Profiles

3 Global Alternative and Complementary Medicine Sales, Revenue, Market Share and Competition by Manufacturer

4 Global Alternative and Complementary Medicine Market Analyses by Regions

5 North America Alternative and Complementary Medicine by Country

6 Europe Alternative and Complementary Medicine by Country

7 Asia-Pacific Alternative and Complementary Medicine by Country

8 South America Alternative and Complementary Medicine by Country

9 Middle East and Africa Alternative and Complementary Medicine by Countries

10 Global Alternative and Complementary Medicine Market Segment by Type

11 Global Alternative and Complementary Medicine Market Segment by Application

12 Alternative and Complementary Medicine Market Forecast (2021-2027)

13 Sales Channel, Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

About Us:

Reports and Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Link:

Alternative and Complementary Medicine Market Insights by Business Overview, Scope, Growth Rate, Market Size and Forecast to 2028 Talking Democrat -...

The 15-year-old Russian figure skater Kamila Valieva had already made headlines at the Olympics in Beijing for landing two quadruple jumps on February 7, a feat no other female competitor has ever pulled off at the games.

Then came the news that a doping test shed taken in advance of a competition in December 2021 showed signs of trimetazidine (TMZ), a heart medication that has been banned by the World Anti-Doping Agency since 2014.

The Court of Arbitration for Sport ruled on February 14 that Valieva could continue to compete in the games; the International Olympic Committee announced that she will not be eligible for any medals until her case is resolved.

While its hard to predict how events will play out, heres whats known about the drug at the heart of the controversy, and some input from a sports medicine doctor on whether this medication can give athletes an edge.

Trimetazidine has been widely used in some European countries since the 1970s but is not approved in the United States. Doctors prescribe the drug to treat chest pain (angina) when more standard medications such as aspirin or beta-blockers arent working. Physicians also prescribe TMZ to treat ringing in the ears (tinnitus), dizziness (vertigo), and some vision disturbances.

Angina occurs when arteries fail to deliver enough blood to a part of the heart that needs oxygen. Though the pain often goes away with rest, angina is usually a warning sign of heart disease.

Though some studies have shown that trimetazidine works well as an adjunct to or alternative to standard treatments for angina, there have been very few randomized double-blind trials of TMZ, and studies that do exist have had conflicting results.

The medication can cause side effects such as restless legs and other movement issues similar to symptoms of Parkinsons disease. Because of these side effects, in 2012, the European Medicines Agency (EMA) recommended that doctors limit the use of TMZ for angina and stop prescribing it to treat other conditions.

Trimetazidine helps the heart work more efficiently by making it easier to access energy.

Normally, the heart gets the energy it needs first by oxidizing fatty acids, then by utilizing glucose as energy a faster and more efficient process.

What trimetazidine does is decrease reliance on the slower fatty acids path and encourage more immediate glucose use, increasing the hearts efficiency. This is helpful for people with angina whose hearts may be deprived of adequate oxygen.

In a study published in a 2018 issue of Advances in Therapy, patients with recently diagnosed angina had fewer incidences of chest pain and were also able to increase their walking distance after being treated with the drug.

Trimetazidine is thought to give endurance athletes a boost because it may help the heart work more efficiently.

TMZ enhances the bodys ability to utilize oxygen under stress. Theoretically, that could provide an athlete in competition and under physical stress with an advantage, enabling them to utilize more oxygen than they normally would, says Cayce Onks, DO, a primary care sports medicine physician at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania.

Thats precisely why it has been banned, though the connection between TMZ and improved performance is still largely theoretical. All Olympic athletes are looking for an edge, says Dr. Onks. When youre talking about a few extra seconds in the air, or a microseconds difference in a race, any advantage can be beneficial.

Unlike some other banned performance-enhancing drugs, like beta-blockers, TMZ does its work without affecting heart rate or blood pressure, explains Onks. Beta-blockers, on the other hand, can slow heart rate and lower blood pressure, obviously a negative for athletes.

As for Valieva, Onks agrees that a clear violation of doping rules occurred. There is no reason for a healthy 15-year-old to be on this medication, he says.

Onks does think the drug might help an athlete get to gold. The difference between first and second place, at this level, can be so infinitesimal that its not measurable, says Onks. Well just never really know the role TMZ might play in terms of that edge.

See the article here:

What Is the Heart Drug Behind the Olympic Skating Controversy? - Everyday Health

Segment 1: Ilyce Glink, owner ofThink Glink MediaandBest Money Moves, joins John to talk about the stock market being down in 2022, what is causing the market fluctuation this week, the continuing strength of the real estate market, how inflation is impacting the real estate market, and the top 10 states with the highest marriage scores.

Segment 2:Chicago Innos Senior EditorJim Dallketells John about the latest in startup innovation includinghow Tocks Nick Kokonas survived the pandemic, and a Chicago startup that wants to be the WeWork of alternative medicine.

Segment 3: WGN reporter andCrains Daily GisthostAmy Guthgives us a round-up of the latest business stories including the Coinbase Super Bowl ad and the amount of crypotcurrency advertising during the game, the U.S. suspending Mexican avocado imports, the price of used cars surging, and how inflation has hit popular Valentines Day items.

Link:

Wintrust Business Lunch 2/14/22: How inflation is impacting the real estate market, used car prices surging, and a cryptocurrency app crashes after...

Amitkumar Mehta, MD, detailed encouraging data presented at the 63rd ASH Annual Meeting for treating mantle cell lymphoma.

Amitkumar Mehta, MD, associate professor of medicine hematology & oncology and director of the Lymphoma Working Group at the University of Alabama Birmingham School of Medicine, spoke with CancerNetwork at the 2021 American Society of Hematology Annual Meeting about a handful of studies focused on the treatment of lymphoma.

Mehta mentioned the POLARIX trial (NCT03274492)1, which looked at standard regimens plus polatuzumab vedotin (Polivy) in diffuse large B-cell lymphoma (DLBCL). He also detailed takeaways from the TRANSFORM (NCT03575351)2 and ZUMA-7 studies (NCT03391466),3 focused on lisocabtagene maraleucel (Breyanzi) vs standard of care for transplant-eligible relapsed/refractory aggressive B-cell non-Hodgkin lymphomas and axicabtagene ciloleucel (Yescarta) vs standard of care for relapsed/refractory DLBCL, respectively.

Transcript:

If you look at frontline data in the POLARIX trial where R-CHOP [rituximab (Rituxan) plus cyclophosphamide, doxorubicin, vincristine, and prednisone] was compared with R-CHP [rituximab plus cyclophosphamide, doxorubicin, and prednisone], [both plus polatuzumab vedotin], that study was positive. Im hopeful that in a select population of large cell lymphoma, especially high-risk, high IPI [International Prognostic Index] disease, a novel combination is emerging for the first time in many years. We will be looking at a treatment which is better than R-CHOP.

For second-line data in the relapse [setting for] large cell lymphoma, you see the CAR T data where primary refractory patients were [treated] with either standard of care consolidated autologous transplant versus CAR T. Two studies, the TRANSFORM study as well as the ZUMA-7 study were positive in that setting. Im hopeful that in the future well have CAR T approved in the second-line setting.

Lastly, parsaclisib was looked at in the marginal zone lymphoma and the follicular lymphoma settings. If you look at marginal zone lymphoma, [which is a] very rare lymphoma, the toxicity profile and the trial design were similar in the weekly and daily dosing group. We saw good activity in marginal zone lymphoma which Im hopeful is also another alternative treatment in [MZL] and in follicular lymphoma. There are many PI3K [inhibitors] approved, but parsaclisib was designed specifically to avoid hepatotoxicities and transaminitis which we did not see in all 3 studies.

Read the original:

Amitkumar Mehta, MD, on Compelling Data From ASH in the Treatment of Lymphoma - Cancer Network

Daniels JP, Khan KS. Chronic pelvic pain in women. BMJ. 2010;341:c4834.

Article Google Scholar

Patnaik SS, Lagan AS, Vitale SG, Buttic S, Noventa M, Gizzo S, Valenti G, Rapisarda AMC, La Rosa VL, Magno C, et al. Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome. Arch Gynecol Obstet. 2017;295(6):134159.

CAS Article Google Scholar

Ahangari A. Prevalence of chronic pelvic pain among women: an updated review. Pain Physician. 2014;17(2):E141-147.

Article Google Scholar

EAU Guidelines on Chronic Pelvic Pain. https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Chronic-Pelvic-Pain-2020.pdf.

Rowlands IJ, Abbott JA, Montgomery GW, Hockey R, Rogers P, Mishra GD. Prevalence and incidence of endometriosis in Australian women: a data linkage cohort study. BJOG. 2021;128(4):65765.

CAS Article Google Scholar

Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019;15(11):66682.

Article Google Scholar

Armour M, Sinclair J, Ng CHM, Hyman MS, Lawson K, Smith CA, Abbott J. Endometriosis and chronic pelvic pain have similar impact on women, but time to diagnosis is decreasing: an Australian survey. Sci Rep. 2020;10(1):16253.

CAS Article Google Scholar

Armour M, Lawson K, Wood A, Smith CA, Abbott J. The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: a national online survey. PLoS ONE. 2019;14(10):e0223316.

CAS Article Google Scholar

Armour M, Ciccia D, Stoikos C, Wardle J. Endometriosis and the workplace: lessons from Australia's response to COVID-19. Aust N Z J Obstet Gynaecol. 2021. https://doi.org/10.1111/ajo.13458.

Lagan AS, Condemi I, Retto G, Muscatello MR, Bruno A, Zoccali RA, Triolo O, Cedro C. Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2015;194:303.

Article Google Scholar

Lagan AS, La Rosa VL, Rapisarda AMC, Valenti G, Sapia F, Chiofalo B, Rossetti D, Ban Frange H, Vrtanik Bokal E, Vitale SG. Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Womens Health. 2017;9:32330.

Article Google Scholar

DAlterio MN, Saponara S, Agus M, Lagan AS, Noventa M, Loi ES, Feki A, Angioni S. Medical and surgical interventions to improve the quality of life for endometriosis patients: a systematic review. Gynecol Surg. 2021;18(1):13.

Article Google Scholar

Rowe HJ, Hammarberg K, Dwyer S, Camilleri R, Fisher JRW. Improving clinical care for women with endometriosis: qualitative analysis of womens and health professionals views. J Psychosom Obstet Gynecol. 2019;42:17480.

Article Google Scholar

O'Hara R, Rowe H, Fisher J. Managing endometriosis: a cross-sectional survey of women in Australia. J Psychosom Obstet Gynaecol. 2020.https://doi.org/10.1080/0167482X.2020.1825374

Lukas I, Kohl-Schwartz A, Geraedts K, Rauchfuss M, Wlfler MM, Hberlin F, von Stephanie O, Eberhard M, Imthurn B, Imesch P, et al. Satisfaction with medical support in women with endometriosis. PLoS ONE. 2018;13(11):e0208023.

Article Google Scholar

Fisher C, Adams J, Hickman L, Sibbritt D. The use of complementary and alternative medicine by 7427 Australian women with cyclic perimenstrual pain and discomfort: a cross-sectional study. BMC Complement Altern Med. 2016;16:129.

Article Google Scholar

Chronic Disease Management (formerly Enhanced Primary Care or EPC). https://www1.health.gov.au/internet/main/publishing.nsf/Content/mbsprimarycare-chronicdiseasemanagement.

Armour M, Ferfolja T, Curry C, Hyman MS, Parry K, Chalmers KJ, Smith CA, MacMillan F, Holmes K. The prevalence and educational impact of pelvic and menstrual pain in Australia: A national online survey of 4202 young women aged 1325 years. J Pediatr Adolesc Gynecol. 2020;33(5):5118.

Article Google Scholar

National Statement on Ethical Conduct in Human Research 2007 (Updated 2018). http://www.nhmrc.gov.au/guidelines/publications/e72.

Simoens S, Hummelshoj L, Dunselman G, Brandes I, Dirksen C, DHooghe T, EndoCost C. Endometriosis cost assessment (the EndoCost study): a cost-of-illness study protocol. Gynecol Obstet Invest. 2011;71(3):1706.

Article Google Scholar

1249.0 - Australian Standard Classification of Cultural and Ethnic Groups (ASCCEG). http://www.abs.gov.au/ausstats/abs@.nsf/mf/1249.0.

Steel A, McIntyre E, Harnett J, Foley H, Adams J, Sibbritt D, Wardle J, Frawley J. Complementary medicine use in the Australian population: results of a nationally-representative cross-sectional survey. Sci Rep. 2018;8(1):17325.

Article Google Scholar

Pledger MJ, Cumming JN, Burnette M. Health service use amongst users of complementary and alternative medicine. N Z Med J. 2010;123(1312):2635.

PubMed Google Scholar

Young K, Fisher J, Kirkman M. Womens experiences of endometriosis: a systematic review and synthesis of qualitative research. J Fam Plan Reprod Health Care. 2015;41(3):225.

Article Google Scholar

Roomaney R, Kagee A. Coping strategies employed by women with endometriosis in a public health-care setting. J Health Psychol. 2015;21(10):225968.

Article Google Scholar

Grundstrm H, Kjlhede P, Berter C, Alehagen S. A challengehealthcare professionals experiences when meeting women with symptoms that might indicate endometriosis. Sex Reprod Healthc. 2016;7:659.

Article Google Scholar

Young K, Fisher J, Kirkman M. Clinicians perceptions of womens experiences of endometriosis and of psychosocial care for endometriosis. Aust N Z J Obstet Gynaecol. 2017;57(1):8792.

Article Google Scholar

Young K, Fisher J, Kirkman M. Womens experiences of endometriosis: a systematic review and synthesis of qualitative research. J Fam Plan Reprod Health Care. 2015;41(3):22534.

Article Google Scholar

Cant RP, Foster MM. Investing in big ideas: utilisation and cost of Medicare Allied Health services in Australia under the Chronic Disease Management initiative in primary care. Aust Health Rev. 2011;35(4):46874.

Article Google Scholar

Fuentes-Mrquez P, Cabrera-Martos I, Valenza MC. Physiotherapy interventions for patients with chronic pelvic pain: a systematic review of the literature. Physiother Theory Pract. 2019;35(12):11318.

Article Google Scholar

Lund I, Lundeberg T. Is acupuncture effective in the treatment of pain in endometriosis? J Pain Res. 2016;9:15765.

Article Google Scholar

Hansen KE, Kesmodel US, Kold M, Forman A. Long-term effects of mindfulness-based psychological intervention for coping with pain in endometriosis: a six-year follow-up on a pilot study. Nordic Psychol. 2017;69(2):1009.

Article Google Scholar

Huijs E, Nap A. The effects of nutrients on symptoms in women with endometriosis: a systematic review. Reprod Biomed Online. 2020;41(2):31728.

CAS Article Google Scholar

National Action Plan for Endometriosis. http://www.health.gov.au/internet/main/publishing.nsf/Content/endometriosis.

Facchin F, Barbara G, Saita E, Mosconi P, Roberto A, Fedele L, Vercellini P. Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference. J Psychosom Obstet Gynecol. 2015;36(4):13541.

Article Google Scholar

Di Donato N, Montanari G, Benfenati A, Monti G, Leonardi D, Bertoldo V, Facchini C, Raimondo D, Villa G, Seracchioli R. Sexual function in women undergoing surgery for deep infiltrating endometriosis: a comparison with healthy women. J Fam Plan Reprod Health Care. 2015;41(4):27883.

Article Google Scholar

Cervigni M, Natale F. Gynecological disorders in bladder pain syndrome/interstitial cystitis patients. Int J Urol. 2014;21(Suppl 1):858.

Article Google Scholar

Tirlapur SA, Kuhrt K, Chaliha C, Ball E, Meads C, Khan KS. The evil twin syndrome in chronic pelvic pain: a systematic review of prevalence studies of bladder pain syndrome and endometriosis. Int J Surg. 2013;11(3):2337.

CAS Article Google Scholar

Spinks J, Hollingsworth B. Policy Implications of Complementary and Alternative Medicine Use in Australia: data from the National Health Survey. J Altern Complem Med. 2012;18(4):3718.

Article Google Scholar

Reid R, Steel A, Wardle J, Trubody A, Adams J. Complementary medicine use by the Australian population: a critical mixed studies systematic review of utilisation, perceptions and factors associated with use. BMC Complem Altern Med. 2016;16(1):176.

Article Google Scholar

Schwartz ASK, Gross E, Geraedts K, Rauchfuss M, Wlfler MM, Hberlin F, von Orelli S, Eberhard M, Imesch P, Imthurn B, et al. The use of home remedies and complementary health approaches in endometriosis. Reprod Biomed Online. 2019;38(2):26071.

Article Google Scholar

Chen L, Michalsen A. Management of chronic pain using complementary and integrative medicine. BMJ. 2017;357:j1284.

Article Google Scholar

Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, Brodszky V, Canis M, Colombo GL, DeLeire T, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012;27(5):12929.

Article Google Scholar

Shafrir AL, Wise LA, Palmer JR, Shuaib ZO, Katuska LM, Vinayak P, Kvaskoff M, Terry KL, Missmer SA. Validity of self-reported endometriosis: a comparison across four cohorts. Hum Reprod. 2021;36(5):126878.

CAS Article Google Scholar

Read the rest here:

Allied health and complementary therapy usage in Australian women with chronic pelvic pain: a cross-sectional study - BMC Women's Health - BMC Blogs...

Inoperable lung cancer may refer to different types of lung cancer that doctors cannot treat with surgery. They may also use the term unresectable lung cancer.

Although a diagnosis of inoperable lung cancer may feel devastating, it does not mean the same as a terminal diagnosis.

Cancer does not respond to treatment in terminal cancer, and doctors have no cure. Conversely, with inoperable cancer, doctors have various other treatments that can improve a persons symptoms and slow down disease progression.

This article looks at inoperable lung cancer, the reasons why surgery is not a viable option, and alternative treatment choices.

No single factor makes lung cancer inoperable, and no two cases are the same.

However, because lung cancer surgery is complex and can have severe effects on other aspects of a persons health, surgeons must carefully consider the following factors:

Surgery for lung cancer has the most chance of success when cancer is in the early stages and has not spread.

However, one of the challenges doctors face is that lung cancer symptoms do not usually appear until the disease is at a late stage. In these cases, doctors may recommend other forms of cancer treatment instead of surgery.

There are two main types of lung cancer and surgeons may consider both as inoperable depending on the above factors.

This is the most common form of lung cancer, making up around 8 in 10 cases. It has three subtypes:

Sometimes called oat cell cancer, SCLC makes up around 1015% of all lung cancers. It grows and spreads faster than NSCLC, meaning that for 7 in 10 people, cancer has spread at the time of diagnosis.

However, because cancer grows quickly, chemotherapy and radiation therapy are usually good treatment options.

Inoperable means that surgery is not a viable option and does not mean the same as terminal. Doctors may not be able to cure the cancer, but they can provide treatment that slows its growth, eases symptoms, and allows an individual to live longer.

Additionally, research into finding the best therapies for lung cancer treatment continues. For example, a 2017 study looked at using radiation therapy alongside a newly formulated chemotherapy regime. The researchers found that the new protocol improved survival rates in people with metastatic NSCLC by up to one year.

Thanks to advances in medicine, lung cancer treatment does not now rely on surgical control of the disease.

Doctors may suggest the following treatment options for individuals with inoperable lung cancer:

A persons outlook depends on the type of lung cancer and the stage at diagnosis. It may also depend on their general health.

In the United States, the overall 5-year survival rate for lung cancer is 21.7%, according to the National Cancer Institute. This means that about 1 in 5 people diagnosed with lung cancer live for 5 years or longer after diagnosis.

This 5-year survival rate is 25% overall for non-small-cell lung cancer and 7% overall for small-cell lung cancer.

Five-year survival rates for people who have NSCLC are:

Five-year survival rates for people who have SCLC are:

Inoperable lung cancer is lung cancer that surgeons cannot remove. Surgery is the best option for localized lung cancer that has not yet spread. However, doctors often diagnose lung cancer at a later stage when it has already spread, meaning that surgery is no longer an option.

Sometimes, lung cancer is inoperable because of the tumors location or because an individual has other health conditions that affect their breathing or mean their general health is poor.

Although a diagnosis of inoperable lung cancer is serious, doctors still have various options for treatments that can ease symptoms, prolong life, and may shrink tumors. Potential treatment options include chemotherapy, radiation therapy, immunotherapy, and photodynamic therapy using lasers.

Additionally, researchers are continuing to seek new therapies that can help people with inoperable lung cancer live longer.

Originally posted here:

Inoperable lung cancer: What to know - Medical News Today

Veganism in the post-pandemic world has become a way of living for many Indians. The mind-shift in being eco-conscious and sustainable has led to different interpretations of veganism, at times confusing it with being vegetarian. However, it's a lifestyle choice that many are making either on ethical grounds or for the sake of their and the planets health. As responsible brands in this transparent and digital era, it is our responsibility to educate the consumers and spread awareness of the concept to drive more adoption. What started out as a food trend has now transcended itself into the beauty industry as well. Social media conversations and celebrities are driving millennials to ask more questions building curiosity around Beauty with compassion. These pro-social shoppers are now digging deeper to understand the ingredients of their daily use products and take into account animal derivatives used in the beauty/cosmetic industry while making purchasing decisions. To put things into perspective, from rabbit eyes, honey, beeswax, gelatin from cows or pigs to ambergris (whale vomit), and so much more is a part of almost every beauty and personal care product we use. So, what happens if everyone on this planet went vegan? Will it impact us positively? The University of Oxford believes it will. It could save 8 million human lives by 2050, which is more than the population of Iceland, Croatia, and Lithuania combined! It could also reduce greenhouse gas emissions from agriculture by two-thirds and lead to healthcare-related savings, and avoided climate damages of $1.5 trillion which is more than the combined GDP of UK, Germany, and France!

What's driving adoption?Conscious consumers, who understand the core concepts of Vegan and Vegetarian well, are majorly driving adoption. However, this radical lifestyle choice is not just ethics-driven. Social media, influencers, and celebrity advocates are making the conversation mainstream. Documentaries like Save Ralph, Cowspiracy are hard-hitting and directly speak to millennials. As next steps, the debate on vegan and vegetarian needs to be further amplified to draw awareness. Beauty brands need to talk about how the adoption of a vegan lifestyle will save more lives and be more transparent about their manufacturing processes.

Making a mindful choice

So many labels and buzzwords can be confusing to even a discerning consumer. While regulations exist, they're not stringent. As consumers, you need to educate yourself on labels and read the fine print; understand what 'clean', 'environment-friendly', 'cruelty-free', 'vegan', and such labels actually mean for a brand. While many have taken to Ayurveda, the popular alternative medicine system is not entirely plant-based.

A responsibility, no longer an option

Read this article:

Vegan beauty is the new fad in 2022 - Times of India

Vaccine hesitancy and opposition to vaccinations were already a much-discussed topic before the pandemic. However, little is known about long-term trends due to a lack of data. Claudia Diehl and Christian Hunkler have now investigated this development. Based on the KiGGS cohort longitudinal study on the health of children, adolescents and young adults in Germany by the Robert Koch Institute (RKI), they analyze the attitudes of parents and corresponding vaccination rates of children born until the beginning of the 2000s and compared them with those of parents whose children were born around the end of the 1980s. Their focus is on childhood vaccinations against measles, mumps and rubella (MMR). Vaccine-hesitant parents are those who irrespective of their actual vaccination decisions have reservations about the MMR vaccination, i.e. they worry about side effects or consider the corresponding diseases to be harmless.

The results have now been published in the journalPLOS ONE. They show that vaccination rates have increased, and the proportion of vaccine-hesitant parents has decreased across birth cohorts from around 10% of children born at the end of the 1980s to around 6% among those born around the year 2000. According to KiGGS data, the group of vaccination sceptics more often includes people with middle and high levels of education as well as people living in large cities, and less often immigrants and East Germans.

However, when taking a closer look at the data, the authors also found an opposite trend namely among the small and shrinking group of vaccine-hesitant parents. Their children are not vaccinated more frequently across the birth cohorts, but on the contrary, less and less frequently. In the corresponding period, the proportion of vaccinated children in this group fell from around 50 to a good 20 percent. The group of vaccine-hesitant parents has apparently become smaller, but also more determined, concludes Claudia Diehl, author of the study. This means that they are more likely to act in line with their vaccine-hesitant views and actually do not have their children vaccinated. Until the end of the 1980s, vaccine-hesitant parents apparently frequently followed the experts recommendations and had their children vaccinated despite their reservations, Diehl suspects. This was less often the case with children born later. In fact, scepticism towards scientifically based medicine was already growing at that time, as was interest in supposed experts from the field of alternative medicine and homoeopathy, who are more often sceptical of vaccines, Diehl notes.

One could assume that the internet, providing easy access to vaccine-critical disinformation, is responsible for this development. But to our surprise, it turned out that the trend described began even before the mass use of the internet. This does not mean that the internet does not play a role in explaining vaccine hesitancy today, however: The trend we are describing ends in the late 1990s, and it was only around that time that a significant part of the population started to use the internet as a source of information.

Although the data do not allow statements about the last two decades, important conclusions can be drawn for the current situation, Claudia Diehl explains: In the case of measles vaccinations, it has become evident that even a small group of determined vaccination sceptics is enough to prevent the elimination of highly contagious viruses despite great efforts.

Go here to see the original:

Vaccine Hesitancy And Vaccine Refusal: The Long-Term Development In Germany - Eurasia Review